key: cord-0714782-l5p89jkj authors: Marembo, Takudzwa; Chimbunde, Prosper; Chipendo, Tendai; Munemo, Clayton; Manangazira, Portia; Bangure, Donewell title: Comparison of Real‐Q 2019‐nCoV and DaAn Gene 2019‐nCoV polymerase chain reaction assays for the detection of SARS‐CoV‐2 date: 2021-12-09 journal: J Clin Lab Anal DOI: 10.1002/jcla.24161 sha: ffb16fc02374725a90cdd7d9e460465bbf6fd3d9 doc_id: 714782 cord_uid: l5p89jkj BACKGROUND: Various nucleic acid amplification assays for the diagnosis of SARS‐CoV‐2 infection have been developed, and there is a need to assess their test performance relative to one another. The aim of this study was to compare the performance characteristics of the Biosewoom Real‐Q 2019‐nCoV assay targeting the E and RdRP genes to DaAn Gene 2019‐nCoV kit targeting the N gene and ORF1ab in the diagnosis of SARS‐CoV‐2. METHODS: We performed a diagnostic comparison study by testing nasopharyngeal samples for SARS‐CoV‐2 using the two reverse transcription polymerase chain reaction (RT‐PCR) assays. Assay agreement was assessed by overall percent agreement, negative percent agreement, positive percent agreement, and Cohen's kappa coefficient. RESULTS: A total of 48 nasopharyngeal samples were tested using the two assays. One sample was invalid, and three showed inconclusive results with Real‐Q; hence, 44 were included for the comparative analysis. Overall, percent agreement between the assays was 93.2% (95% CI 81.3%–98.6%), Positive percent agreement (PPA) was 86.4% (95% CI 65.1%–97.1%) and negative percent agreement (NPA) was 100% (95% CI 84.6%–100%). The kappa coefficient was 0.86 (95% CI 0.72–1.01). Three samples (6.8%) were positive with DaAn gene kit and negative with Real‐Q. The fluorescence intensity for Real‐Q reporter dyes was low. CONCLUSION: The two kits showed high levels of concordance in their detection of SARS‐CoV‐2 despite having different gene targets. The Biosewoom kit can be improved through addressing the fluorescence intensity of the target dyes, and feedback was given to the manufacturer. In the clinical management and outbreak control of the COVID-19 disease, rapid collection and laboratory testing of appropriate specimen from patients are very critical. The diagnosis of SARS-CoV-2 involves use of assays that detect viral nucleic acid or antigen from samples from the respiratory system (such as nasal swabs). Currently, RT-PCR is the most suitable laboratory diagnostic test for COVID-19 as other laboratory methods (viral culture, antigen testing, and serology) have various limitations. [8] [9] [10] To date, various commercial kits for the detection of SARS-CoV-2 using RT-PCR have been developed. The PCR targets of the available kits include S, RdRP, N, and E genes as well as functionally important open reading frames 1a and 1b (ORF1ab). Most kits are multiplexed to detect at least two genes. 11 There is a need to understand the relative test performance of these assays to guide laboratories' selection of assays and understand advantages and disadvantages of methods that may be used in parallel. In this study, the performance characteristics of the Biosewoom Real-Q 2019-nCoV RT-PCR kit (E and RdRP genes) for the detection of SARS-CoV-2 was compared to those of DaAn Gene 2019-nCoV kit (N gene and ORF1ab), which has been in use in Zimbabwe. This was an operational laboratory-based cross-sectional study, where the Real-Q 2019 nCoV (Biosewoom, Korea) kit was being evaluated before being adopted for testing. The DaAn gene kit, which has been use in Zimbabwe, was used as the non-reference standard. Nasopharyngeal samples collected in viral transport medium (VTM) for SARS-CoV-2 testing were used. Total nucleic acid from the nasopharyngeal swabs in viral transport medium (VTM) was extracted using a DaAn Gene nucleic acid extraction kit (DaAn Gene Co, Ltd., of Sun Yat-sen University, China) as per manufacturer's instructions. The extracted DNA was stored at −20°C awaiting SARS-CoV-2 RT-PCR. The master mix was prepared by mixing 12.5 µl of 2X PCR mixture, The results from PCR were recorded onto Excel Spreadsheet. Overall percent agreement, positive percent agreement (PPA), negative percent agreement (NPA), and associated 95% confidence intervals (CI) were performed with the DaAn gene kit serving as the non-reference standard method. Cohen's kappa coefficient (κ) of qualitative results (detected/non-detected) between the two assays with 95% CI was also calculated. The results were analyzed using the recommendations from FDA's statistical guidance on reporting results from studies evaluating diagnostic tests handbook. The permission to carry out the comparison using the remnant samples was granted by the National Microbiology Reference Laboratory as the study was used as the in-house evaluation of the Real-Q kit for adoption in national testing. All experiments were examined and approved by the appropriate Ethics Committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Figure 1 shows the amplification plots from the same sample processed with Real-Q 2019-nCoV-2 (Biosewoom) and DaAn Gene kit, respectively. The global challenge posed by the SARS-CoV-2 virus has brought more challenges to the resource limited settings including Africa. Despite the efforts being made to set up molecular diagnostic laboratories, there is also the need to procure high-quality diagnostic test kits. There are several kits that have managed to reach Zimbabwe, and hence, comparison of these kits is essential before they are adopted for use. With the increase in global demand for SARS-CoV-2 testing, there is a high likelihood of shortages in the preferred PCR testing kits and hence the need for switching to alternative PCR test kits. 12 In this operational research, the Real-Q 2019-nCoV-2 (New test) was compared to the DaAn Gene PCR kit (Non-Reference Standard) to determine their qualitative performance in the detection of SARS-CoV-2. DaAn gene kit was the best performing PCR kit, being the only kit with a 100% detection rate in level 4, lowest limit We would like to acknowledge the African Institute of Biomedical Sciences (AiBST) for availing the equipment and infrastructure for laboratory work. The authors have declared that no competing interests exist. The data that support the findings of this study are available from the corresponding author upon reasonable request. Takudzwa Marembo https://orcid.org/0000-0003-0293-4088 Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis COVID-19 public health emergency of international concern (PHEIC) Global research and innovation forum Cases and 621,153 deaths from COVID-19 virus pandemic -worldometer Ministry of health and child care -latest updates SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview Transmission of SARS-CoV-2: implications for infection prevention precautions Viral load of SARS-CoV-2 in clinical samples Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens Laboratory diagnosis of emerging human coronavirus infections -the state of the art Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2 An alternative workflow for molecular detection of SARS-CoV-2 -escape from the NA extraction kit-shortage Analytical performance evaluation of five RT-PCR kits for severe acute respiratory syndrome coronavirus 2 Comparative performance of four nucleic acid amplification tests for SARS-CoV-2 virus Challenging the proposed causes of the PCR plateau phase